Biogen Inc. buy Royal Bank of Canada
Start price
31.07.23
/
50%
€245.60
Target price
31.07.24
€339.11
Performance (%)
-16.25%
Price
10.05.24
€205.70
Summary
This prediction is currently active. The price of Biogen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.25%. This prediction currently runs until 31.07.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | 1.781% | 1.781% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $379.00 to $374.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat